Ben Lahmann

Ben Lahmann is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as the Associate Director, Thought Leader Liaison at UCB since May 2022. Prior roles include Rare Disease Specialist at Amryt Pharma plc and Senior Territory Business Manager at Bristol-Myers Squibb and SUN PHARMA. Ben's career began at UCB Pharma as a Professional Sales Representative and includes significant positions in dermatology and biologics sales with companies such as Allergan and Galderma Laboratories. Ben holds a degree from Washington State University.